| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/04/2011 | EP2316851A1 Antibody inhibitors of GDF-8 and uses thereof |
| 05/04/2011 | EP2316850A2 HASylated polypeptides, especially HASylated erythropoietin |
| 05/04/2011 | EP2316849A2 Polypeptides comprising RER, derivatives and uses thereof |
| 05/04/2011 | EP2316848A1 Transporter genes OATP-B, C, D and E |
| 05/04/2011 | EP2316847A2 Modified clostridial toxins with enhanced targeting capabilities for endogenous clostridial toxin receptor systems |
| 05/04/2011 | EP2316845A1 Specific binding agents of human angiopoietin-2 |
| 05/04/2011 | EP2316843A1 Isolation of five novel genes coding for new Fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma |
| 05/04/2011 | EP2316497A2 Supplemented matrices for the repair of bone fractures |
| 05/04/2011 | EP2316487A1 Recombinant IL-9 antibodies & uses thereof |
| 05/04/2011 | EP2316480A1 Chimeric tymovirus-like particles |
| 05/04/2011 | EP2316479A2 Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments |
| 05/04/2011 | EP2316467A1 Use of a prolactin variant for treating cancer |
| 05/04/2011 | EP2315834A1 The tuberculosis rv2386c protein, compositions and uses thereof |
| 05/04/2011 | EP2315833A2 Vectors for delivery of light-sensitive proteins and methods of use |
| 05/04/2011 | EP2315828A2 Culture of cells |
| 05/04/2011 | EP2315776A2 T cell receptors and related materials and methods of use |
| 05/04/2011 | EP2315775A2 Angiopoietin derived peptides |
| 05/04/2011 | EP2315774A1 Plants having enhanced yield-related traits and a method for making the same |
| 05/04/2011 | EP2315773A1 Novel compositions and methods |
| 05/04/2011 | EP2315772A1 Production, formulation, and uses of stable liquid harpin protein formulations |
| 05/04/2011 | EP2315771A2 Glycopeptide constructs and uses thereof |
| 05/04/2011 | EP2315747A2 Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides |
| 05/04/2011 | EP2315604A2 Dicarba-analgues of octreotide |
| 05/04/2011 | EP2315597A1 Novel compositions and methods |
| 05/04/2011 | EP1733231B1 Peptides and peptidomimetics binding to cd23 |
| 05/04/2011 | EP1668156B1 Method of diagnosing breast cancer |
| 05/04/2011 | EP1629091B1 Composition containing the polyprotein ns3/ns4 and the polypeptide ns5b of hcv, expression vectors comprising corresponding nucleic sequences and the therapeutic application thereof |
| 05/04/2011 | EP1581560B1 Anti-idiotypic antibodies against factor viii inhibitor and uses thereof |
| 05/04/2011 | EP1414299B1 Method for making a homogenous doxorubicin -transferrin conjugate |
| 05/04/2011 | EP1294746B1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 05/04/2011 | EP1144624B1 Human and mouse trek-1 potassium channel protein and their use |
| 05/04/2011 | EP0815233B1 Novel avian cytokines and genetic sequences encoding same |
| 05/04/2011 | CN1961000B Hybrid polypeptides with selectable properties |
| 05/04/2011 | CN1860230B Nucleic acids from rice conferring resistance to bacterial blight disease caused by xanthomonas spp. |
| 05/04/2011 | CN1856576B Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| 05/04/2011 | CN1826349B Wound care compositions |
| 05/04/2011 | CN1423520B Compositions and methods for modulation of plant cell division |
| 05/04/2011 | CN102047113A Composition, kit and method for detecting neuropathy |
| 05/04/2011 | CN102047112A Composition, kit and method for detecting aging and disease associated with vascular disorder |
| 05/04/2011 | CN102046797A Plants having enhanced yield-related traits and a method for making the same |
| 05/04/2011 | CN102046795A Therapy delivery and monitoring using a gene of interest-reporter fusion protein and optical imaging |
| 05/04/2011 | CN102046661A Polypeptide-polymer conjugates and methods of use thereof |
| 05/04/2011 | CN102046657A Antibodies directed to angiopoietin-1 and angiopoietin-2 and use thereof |
| 05/04/2011 | CN102046653A Method of controlling a polypeptide modification reaction |
| 05/04/2011 | CN102046652A Highly bridged peptides from Actinomadura namibiensis |
| 05/04/2011 | CN102046651A Novel sequences of brachyspira, immunogenic compositions, methods for preparation and use thereof |
| 05/04/2011 | CN102046650A Infection inhibitor |
| 05/04/2011 | CN102046206A Fully synthetic albumin analogue |
| 05/04/2011 | CN102041260A Grouper interleukin EcIL-1beta gene, coded protein, and preparation method and application thereof |
| 05/04/2011 | CN102041258A Preparation and application of monoclonal antibody for promyelocytic leukemia (PML) proteins |
| 05/04/2011 | CN102041238A Lactobacillus plantarum, method for fermenting and preparing bacteriocin of Lactobacillus plantarum, and application of Lactobacillus plantarum and bacteriocin |
| 05/04/2011 | CN102040661A Artificial antigen and specific antibody of veterinary drug penicillin G degradation product benzylpenicilloic thiazole acid |
| 05/04/2011 | CN102040660A Recombinant protein as BNP (Brain Natriuretic Peptide) immunodiagnostic reagent standard as well as preparation method and application thereof |
| 05/04/2011 | CN102040659A Method for separating and purifying recombinant human erythropoietin |
| 05/04/2011 | CN102040658A Schistosoma japonica polypeptide with immunogenicity and application thereof |
| 05/04/2011 | CN102040657A Sequence optimization and efficient expression of bilin-binding protein (BBP) |
| 05/04/2011 | CN102040656A Rice dehydrin protein with antibacterial activity and application thereof |
| 05/04/2011 | CN102040655A Method for positioning and expressing extrinsic proteins in cell nucleuses and/or chloroplasts |
| 05/04/2011 | CN102038932A Metal-binding compounds and uses therefor |
| 05/04/2011 | CN101555484B Recombinant human HMBOX1 expression vector, expression product thereof and antibody and application thereof |
| 05/04/2011 | CN101544982B Novel nucleic acid sequence of gamma-alcohol soluble protein gene and application thereof |
| 05/04/2011 | CN101492656B Glutamine-auxothrophic human cells capable of producing proteins and capable of growing in a glutamine-free medium |
| 05/04/2011 | CN101469331B Method for preparing streptavidin labeled phycoerythrobilin combined phycocyanin fluorescent protein |
| 05/04/2011 | CN101456906B Rice protein OsSRM and coding gene and application thereof |
| 05/04/2011 | CN101413009B Preparation of human amylin mutant-pramlintide with modified structure |
| 05/04/2011 | CN101367873B Modified glucagon sample peptide-1analogue and modifying matter, and uses thereof |
| 05/04/2011 | CN101348791B Populus euphratica Oliv hydrotropic gene PeXET and promoter thereof |
| 05/04/2011 | CN101314617B Novel snake venom polypeptide, preparation and application thereof |
| 05/04/2011 | CN101270148B Preparation for high-purity laver phycoerythrin with one-step chromatography |
| 05/04/2011 | CN101225119B Porphyra yezoensis polysaccharide and protein synchronous ultrasonic auxiliary extraction method |
| 05/04/2011 | CN101115839B Method for inhibiting fibrogenesis by an rhdecorin-fc fusion protein |
| 05/04/2011 | CN101098887B Hemopexin-like structure as polypeptide-scaffold |
| 05/04/2011 | CN101066993B Recombinant staphylococcus aureus enterotoxin M and its preparation and application |
| 05/03/2011 | US7935868 Spinach line MSA66-1119M |
| 05/03/2011 | US7935867 Spinach line SSB66-1087F |
| 05/03/2011 | US7935866 Spinach line SMB66-1086M |
| 05/03/2011 | US7935865 Spinach line SMB66-1082F |
| 05/03/2011 | US7935864 Spinach line SMB66-1100M |
| 05/03/2011 | US7935805 Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof |
| 05/03/2011 | US7935789 Centromeric protein shugoshin |
| 05/03/2011 | US7935788 Reverse cumate repressor mutant |
| 05/03/2011 | US7935787 Formulations which stabilize and inhibit precipitation of immunogenic compositions |
| 05/03/2011 | US7935786 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 05/03/2011 | US7935785 Selective substrates for matrix metalloproteinases |
| 05/03/2011 | US7935784 Immunoglobulin fusion which targets extracellullar domain of human estrogen receptor for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 05/03/2011 | US7935676 Nucleic acid construct containing a nucleic acid derived from the genome of hepatitis C virus (HCV) of genotype 2A, and a cell having such nucleic acid construct introduced therein |
| 05/03/2011 | US7935675 Immunostimulatory nucleic acid molecules |
| 05/03/2011 | US7935671 Pantropic neurotrophic factors |
| 05/03/2011 | US7935531 Methods for the early diagnosis of ovarian cancer |
| 05/03/2011 | US7935526 hERG channel-expressing cell |
| 05/03/2011 | US7935525 Inhibition of ATF2 activity to treat cancer |
| 05/03/2011 | US7935510 Modulating the expression of a gene in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic organisms |
| 05/03/2011 | US7935509 Intracellular production of a nuclease |
| 05/03/2011 | US7935506 Method for producing a lower alkyl ester of α-L-aspartyl-L-phenylalanine |
| 05/03/2011 | US7935501 Recombinant production of antimicrobial peptides |
| 05/03/2011 | US7935493 Protein fragment complementation assays for high-throughput and high-content screening |
| 05/03/2011 | US7935491 Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer |
| 05/03/2011 | US7935490 Immunodiagnostic assays using reducing agents |
| 05/03/2011 | US7935487 Method of detecting tumor-associated DNA in plasma or serum from humans without cancer |
| 05/03/2011 | US7935484 Identifying non-mutated hypermethylated DNA in a human without cancer having colorectal adenoma; using extracellular mutant oncogenes to diagnose cell proliferative disorders |